Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420

Watchlist Manager
Shanghai Shyndec Pharmaceutical Co Ltd Logo
Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
Watchlist
Price: 12.1 CNY -4.72% Market Closed
Market Cap: 16.2B CNY
Have any thoughts about
Shanghai Shyndec Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shanghai Shyndec Pharmaceutical Co Ltd stock under the Base Case scenario is 20 CNY. Compared to the current market price of 12.1 CNY, Shanghai Shyndec Pharmaceutical Co Ltd is Undervalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
20 CNY
Undervaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Shanghai Shyndec Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Shanghai Shyndec Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Shanghai Shyndec Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Shanghai Shyndec Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Shanghai Shyndec Pharmaceutical Co Ltd.

What unique competitive advantages
does Shanghai Shyndec Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Shanghai Shyndec Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide P/S
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide P/E
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide P/OCF
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide P/FCFE
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide P/B
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/S
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/GP
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/EBIT
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/OCF
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/FCFF
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide EV/IC
for Shanghai Shyndec Pharmaceutical Co Ltd.

Show me price targets
for Shanghai Shyndec Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Shanghai Shyndec Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Shanghai Shyndec Pharmaceutical Co Ltd?

What are the Net Income projections
for Shanghai Shyndec Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Shanghai Shyndec Pharmaceutical Co Ltd?

What are the EPS projections
for Shanghai Shyndec Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Shanghai Shyndec Pharmaceutical Co Ltd?

What are the EBIT projections
for Shanghai Shyndec Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Shanghai Shyndec Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Shanghai Shyndec Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shanghai Shyndec Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shanghai Shyndec Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shanghai Shyndec Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Shanghai Shyndec Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shanghai Shyndec Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Shanghai Shyndec Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide ROE
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide ROA
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide ROIC
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide ROCE
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Gross Margin
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Operating Margin
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Net Margin
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide FCF Margin
for Shanghai Shyndec Pharmaceutical Co Ltd.

Show all solvency ratios
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide D/E Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide D/A Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Quick Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Current Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

Provide Cash Ratio
for Shanghai Shyndec Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shanghai Shyndec Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shanghai Shyndec Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Shanghai Shyndec Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shanghai Shyndec Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai Shyndec Pharmaceutical Co Ltd

Current Assets 11.4B
Cash & Short-Term Investments 6.9B
Receivables 2B
Other Current Assets 2.6B
Non-Current Assets 8.6B
Long-Term Investments 1.5B
PP&E 5.8B
Intangibles 1B
Other Non-Current Assets 189.5m
Current Liabilities 4.6B
Accounts Payable 876.4m
Accrued Liabilities 304.5m
Short-Term Debt 674m
Other Current Liabilities 2.8B
Non-Current Liabilities 2.4B
Long-Term Debt 52.8m
Other Non-Current Liabilities 2.3B
Efficiency

Earnings Waterfall
Shanghai Shyndec Pharmaceutical Co Ltd

Revenue
11.6B CNY
Cost of Revenue
-7.3B CNY
Gross Profit
4.3B CNY
Operating Expenses
-2.9B CNY
Operating Income
1.5B CNY
Other Expenses
-387.5m CNY
Net Income
1.1B CNY

Free Cash Flow Analysis
Shanghai Shyndec Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai Shyndec Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
ROIC is Increasing
51/100
Profitability
Score

Shanghai Shyndec Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai Shyndec Pharmaceutical Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
71/100
Solvency
Score

Shanghai Shyndec Pharmaceutical Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai Shyndec Pharmaceutical Co Ltd

Wall Street analysts forecast Shanghai Shyndec Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Shyndec Pharmaceutical Co Ltd is 19.91 CNY with a low forecast of 19.72 CNY and a high forecast of 20.5 CNY.

Lowest
Price Target
19.72 CNY
63% Upside
Average
Price Target
19.91 CNY
65% Upside
Highest
Price Target
20.5 CNY
69% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shanghai Shyndec Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shanghai Shyndec Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shanghai Shyndec Pharmaceutical Co Ltd Logo
Shanghai Shyndec Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

16.2B CNY

Dividend Yield

0%

Description

Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 11,937 full-time employees. The company went IPO on 2004-06-16. The firm's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The firm also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Contact

SHANGHAI
Shanghai
No. 378 Jianlu Road, Pudong New Area
+862162510990
www.shyndec.com

IPO

2004-06-16

Employees

11 937

Officers

Vice Chairman of the Board & President
Mr. Yong Liu
VP & General Counsel
Mr. Xian Lin Li
VP & Secretary of the Board of Directors
Mr. Dongsong Wei
Vice President
Mr. Feng Ni
Chief Financial Officer
Mr. Jing Zu

See Also

Discover More
What is the Intrinsic Value of one Shanghai Shyndec Pharmaceutical Co Ltd stock?

The intrinsic value of one Shanghai Shyndec Pharmaceutical Co Ltd stock under the Base Case scenario is 20 CNY.

Is Shanghai Shyndec Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12.1 CNY, Shanghai Shyndec Pharmaceutical Co Ltd is Undervalued by 39%.

Back to Top